Outlook Therapeutics, Inc. (OTLK) Financials

OTLK Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 21.7 million 46.0 million
2023-09-30 32.3 million 46.7 million
2023-06-30 44.4 million 50.0 million
2023-03-31 54.0 million 43.5 million

OTLK Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -13.0 million 1.3 million
2023-09-30 -12.7 million 1.4 million
2023-06-30 -13.2 million 1.4 million
2023-03-31 -8.1 million 1.4 million

OTLK Net Income

No data available :(

OTLK Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 10.4 million - 1084
2023-09-30 23.4 million - 4267
2023-06-30 33.7 million - 7349
2023-03-31 43.6 million - 14261

OTLK Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 260.3 million
2023-09-30 250.2 million
2023-06-30 256.9 million
2023-03-31 256.7 million

OTLK Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 4.5 million 5.8 million -
2023-09-30 - 4.9 million 7.5 million -
2023-06-30 - 11.1 million 7.0 million -
2023-03-31 - 545000 6.3 million -

OTLK Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 28195
2023-09-30 - 11217
2023-06-30 - 11192
2023-03-31 - 11001

OTLK

Price: $8.60

52 week price:
4.00
40.60

Earnings Per Share: -4.00 USD

P/E Ratio: -1.87

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 308347

Market Capitalization: 200.4 million

Links: